Literature DB >> 23550741

Medication use among Australian adults with intellectual disability in primary healthcare settings: a cross-sectional study.

Tan N Doan1, Nicholas G Lennox, Miriam Taylor-Gomez, Robert S Ware.   

Abstract

BACKGROUND: There is concern about widespread medication use by people with intellectual disability (ID), especially psychotropic and anticonvulsant agents. However, there is sparse information on prescribing patterns in Australia.
METHOD: This cross-sectional study was conducted between 2000 and 2002 among adults with ID who live in the community in Brisbane, Australia. Medication data were extracted from a health screening tool. Demographic and medical data were collected from telephone interviews and medical records.
RESULTS: Of 117 participants, 35% were prescribed psychotropic medications, most commonly antipsychotics, and 26% anticonvulsants. Complementary medications (vitamins, minerals, amino acids, fish oil, and herbal products) were used by 29% of participants. After adjusting for potentially confounding variables, psychotropic medication use was significantly associated with having a psychiatric illness (adjusted odds ratio = 4.6, 95% CI [1.0, 20.6]) and challenging behaviours (4.4, [1.1, 17.3]).
CONCLUSIONS: People with ID use a broad range of medications. Psychotropic medications continue to be the most predominant agents prescribed for this population. Psychotropic medication use is positively associated with having a psychiatric illness and challenging behaviours.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23550741     DOI: 10.3109/13668250.2013.778968

Source DB:  PubMed          Journal:  J Intellect Dev Disabil        ISSN: 1366-8250


  16 in total

Review 1.  Medication use and potentially inappropriate prescribing in older adults with intellectual disabilities: a neglected area of research.

Authors:  Maire O'Dwyer; Philip McCallion; Mary McCarron; Martin Henman
Journal:  Ther Adv Drug Saf       Date:  2018-06-20

2.  Mental, Neurological, and Somatic Comorbidities and Their Treatment in Persons With Intellectual Disability.

Authors:  Markus Weih; Sabine Köhler; Norbert Schöll; Mandy Schulz; Ramona Hering
Journal:  Dtsch Arztebl Int       Date:  2022-06-17       Impact factor: 8.251

3.  Identifying Medication Management Smartphone App Features Suitable for Young Adults With Developmental Disabilities: Delphi Consensus Study.

Authors:  Teresa M Salgado; Alexa Fedrigon; Donna Riccio Omichinski; Michelle A Meade; Karen B Farris
Journal:  JMIR Mhealth Uhealth       Date:  2018-05-23       Impact factor: 4.773

4.  Fall-risk-increasing drugs and falls requiring health care among older people with intellectual disability in comparison with the general population: A register study.

Authors:  Anna Axmon; Magnus Sandberg; Gerd Ahlström; Patrik Midlöv
Journal:  PLoS One       Date:  2018-06-19       Impact factor: 3.240

5.  Primary care for people with an intellectual disability - what is prescribed? An analysis of medication recommendations from the BEACH dataset.

Authors:  Carmela Salomon; Helena Britt; Allan Pollack; Julian Trollor
Journal:  BJGP Open       Date:  2018-05-30

6.  Psychotropic medication and psychotherapeutic treatment of adults with intellectual disabilities (PROMPT-ID): a cross-sectional, epidemiological study in Saxony, Germany.

Authors:  Andrea Koch; Julia Dobrindt; Matthias Schützwohl
Journal:  BMJ Open       Date:  2018-12-19       Impact factor: 2.692

7.  Multiple physical and mental health comorbidity in adults with intellectual disabilities: population-based cross-sectional analysis.

Authors:  Sally-Ann Cooper; Gary McLean; Bruce Guthrie; Alex McConnachie; Stewart Mercer; Frank Sullivan; Jill Morrison
Journal:  BMC Fam Pract       Date:  2015-08-27       Impact factor: 2.497

8.  Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study.

Authors:  Máire O'Dwyer; Jure Peklar; Philip McCallion; Mary McCarron; Martin C Henman
Journal:  BMJ Open       Date:  2016-04-04       Impact factor: 2.692

9.  Prescription of potentially inappropriate medications among older people with intellectual disability: a register study.

Authors:  Anna Axmon; Magnus Sandberg; Gerd Ahlström; Patrik Midlöv
Journal:  BMC Pharmacol Toxicol       Date:  2017-10-25       Impact factor: 2.483

10.  A study of harmful drug-drug interactions due to polypharmacy in hospitalized patients in Goa Medical College.

Authors:  Akshay Khandeparkar; Padmanabh V Rataboli
Journal:  Perspect Clin Res       Date:  2017 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.